We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$314M
AUM Growth
+$29M
Cap. Flow
-$6.82M
Cap. Flow %
-2.17%
Top 10 Hldgs %
35.88%
Holding
134
New
8
Increased
17
Reduced
65
Closed
7

Top Buys

Rank Stock Value
1
PCH
PotlatchDeltic
PCH
+$1.37M
2
LMT icon
Lockheed Martin
LMT
+$1.01M
3
CME icon
CME Group
CME
+$549K
4
FNV icon
Franco-Nevada
FNV
+$511K
5
MAR icon
Marriott International
MAR
+$450K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.29M
2
AIG icon
American International
AIG
+$1.04M
3
LIN icon
Linde
LIN
+$641K
4
NKE icon
Nike
NKE
+$613K
5
HD icon
Home Depot
HD
+$592K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.65%
2 Technology 17.38%
3 Financials 15.08%
4 Industrials 12.43%
5 Healthcare 11.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
26
FedEx
FDX
$72.7B
$4.17M 1.33%
16,070
-965
-6% -$267K
SBUX icon
27
Starbucks
SBUX
$120B
$3.53M 1.12%
33,035
+215
+0.7% +$20.5K
TMO icon
28
Thermo Fisher Scientific
TMO
$213B
$3.42M 1.09%
7,350
– –
BMY icon
29
Bristol-Myers Squibb
BMY
$133B
$3.21M 1.02%
51,637
+200
+0.4% +$12.3K
BRK.B icon
30
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.16M 1.01%
13,622
– –
FNV icon
31
Franco-Nevada
FNV
$41.1B
$2.87M 0.91%
22,840
+3,790
+20% +$511K
HOLX
32
DELISTED
Hologic
HOLX
$2.81M 0.89%
38,575
-175
-0.5% -$12.4K
FMC icon
33
FMC
FMC
$1.34B
$2.8M 0.89%
24,445
-800
-3% -$89.1K
HON icon
34
Honeywell
HON
$77B
$2.77M 0.88%
13,810
-1,034
-7% -$188K
LMT icon
35
Lockheed Martin
LMT
$134B
$2.74M 0.87%
7,725
+2,735
+55% +$1.01M
BAC icon
36
Bank of America
BAC
$435B
$2.56M 0.82%
84,734
-900
-1% -$24.1K
CL icon
37
Colgate-Palmolive
CL
$73.1B
$2.52M 0.8%
29,453
-800
-3% -$66.2K
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$4.36T
$2.49M 0.79%
28,400
– –
MSGS icon
39
Madison Square Garden
MSGS
$9.48B
$2.49M 0.79%
13,530
+100
+0.7% +$16.5K
NVO
40
Novo Nordisk
NVO
$208B
$2.47M 0.79%
70,900
-7,400
-9% -$256K
CI icon
41
Cigna
CI
$73.7B
$2.4M 0.76%
11,545
-632
-5% -$124K
JNJ icon
42
Johnson & Johnson
JNJ
$618B
$2.38M 0.76%
15,119
-350
-2% -$51.6K
MRK icon
43
Merck
MRK
$322B
$2.36M 0.75%
30,242
-3,768
-11% -$288K
PCH
44
DELISTED
PotlatchDeltic
PCH
$2.35M 0.75%
46,825
+29,750
+174% +$1.37M
CAT icon
45
Caterpillar
CAT
$375B
$2.32M 0.74%
12,725
– –
GILD icon
46
Gilead Sciences
GILD
$162B
$2.27M 0.72%
39,113
-4,079
-9% -$246K
CVX icon
47
Chevron
CVX
$392B
$2.26M 0.72%
26,761
+950
+4% +$76.9K
IBM icon
48
IBM
IBM
$211B
$2.2M 0.7%
18,221
-2,583
-12% -$299K
NVS icon
49
Novartis
NVS
$297B
$2.08M 0.66%
21,985
– –
DIS icon
50
Walt Disney
DIS
$167B
$2.05M 0.65%
11,349
-345
-3% -$49.5K
1
2
3 4 5

Similar funds

GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
CFGSD
Compass Financial Group (South Dakota) Sioux Falls, South Dakota $715M AUM 15.96% 1-Year Est. Return
LFA
Legacy Financial Advisors Covington, Kentucky $715M AUM 22.34% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

EagleClaw Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, EagleClaw Capital Management held 134 positions worth $314M, up 10% from $285M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

EagleClaw Capital Management's Q4 2020 filing shows 8 new, 17 increased, 65 reduced and 7 closed positions. Its largest new stake was ARK Genomic Revolution ETF: 3,930 shares worth $365K. The largest sale was Apple, an estimated $1.29M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • EagleClaw Capital Management's largest Q4 2020 buy was ARK Genomic Revolution ETF: 3,930 shares worth $365K.
  • EagleClaw Capital Management added most to PotlatchDeltic in Q4 2020, an estimated $1.37M increase.
  • EagleClaw Capital Management's biggest Q4 2020 reduction was Apple, cutting an estimated $1.29M.
  • EagleClaw Capital Management fully exited Brown-Forman Class B in Q4 2020, selling an estimated $452K.
  • EagleClaw Capital Management's ten largest holdings make up 36% of its $314M portfolio in Q4 2020.
  • EagleClaw Capital Management opened 8 new positions and closed 7 in Q4 2020.
  • EagleClaw Capital Management's portfolio value rose 10% quarter-over-quarter to $314M.

Based on EagleClaw Capital Management's 13F filing for Q4 2020, filed 11 Feb 2021.